Biomedical Alliance in Europe

Tweet this page
<
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 03 Sep 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

100,000€ - 199,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

3 Fte (3)

Lobbyists with EP accreditation

0

High-level Commission meetings

4

Lobbying Costs over the years

  • Info

    Biomedical Alliance in Europe   (the BioMed Alliance)

    EU Transparency Register

    876034021209-88 First registered on 30 Mar 2016

    Goals / Remit

    Biomedical Alliance in Europe (BioMed Alliance) is a unique initiative of 35 eading European medical societies uniting more than 400,000 researchers and health professionals.

    The BioMed Alliance was created in 2010 to gather strength across different disciplines and areas in biomedical and health research to address common issues at European level.

    The BioMed Alliance is committed to promoting excellence in European biomedical research and innovation with the goal of improving the health and well-being of all European citizens.

    BioMed Alliance aims:

    To provide a network for our members to speak with a unified voice and interact with EU policy makers on key topics for European biomedical and health research and on metters relevant for our memebrs.

    To provide recommendations for policy and decision makers on facilitating and improving biomedical research in Europe

    To advocate for an EU regulatory environment that promotes European excellence and innovation in (...)

    Main EU files targeted

    Health research: Animal Research, Horizon Europe, Horizon 2020, public-private partnerships, European Innovation Council,
    Public health
    AMR
    Ethics
    Regulatory issues:GDPR, MDR, IVDR, clinical trials, EHDS, AI
    Continuous Medical Education

    Address

    Head Office
    Rue de la Loi, 34/36
    Brussels 1000
    BELGIUM
    EU Office
    Rue de la Loi, 34/36
    Brussels 1000
    BELGIUM

    Website

  • People

    Total lobbyists declared

    3

    Employment timeLobbyists
    100%3

    Lobbyists (Full time equivalent)

    3

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 21 Nov 2024

    Name Start date End Date
    Marieke Meijer 18 May 2023 18 May 2024
    Maria Loredana Simulescu 23 May 2023 23 May 2024
    Marieke Meijer 20 Mar 2019 20 Mar 2020
    Maria Loredana Simulescu 19 Mar 2019 01 Apr 2020
    Maria Loredana Simulescu 14 Feb 2018 15 Feb 2019
    Maria Loredana Simulescu 19 Oct 2016 18 Oct 2017

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Trade unions and professional associations

  • Networking

    Affiliation

    http://www.biomedeurope.org/about/members.html

    https://www.biomedeurope.org/about/cooperation.html

    Member organisations

    http://www.biomedeurope.org/about/members.html

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    100,000€ - 199,999€

    Major contributions in closed year

    None declared

    Major contributions in current year

    TypeNameAmount
    Grant EU4Health programme 192,500€

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    100,000€ - 199,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    Medical Device Coordination Group#X03565#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3565 #OBSERVER #C#Professionals10 - International Matters#X03565/11#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100607 #OBSERVER #C#Professionals07 - New Technologies#X03565/9#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100604 #OBSERVER #C#Professionals08 - EUDAMED#X03565/13#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100886 #OBSERVER #C#Professionals03 - Clinical Investigation and Evaluation (CIE)#X03565/5#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100600 #OBSERVER #C#Professionals04 - Post-Market Surveillance and Vigilance (PMSV)#X03565/6#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100601 #OBSERVER #C#Professionals06 - Borderline and Classification (B&C)#X03565/8#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100603 #OBSERVER #C#Professionals09 - Unique Device Identification (UDI)#X03565/10#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100606 #OBSERVER #C#Professionals11 - In vitro Diagnostic Medical Devices (IVD)#X03565/12#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100608 #OBSERVER #C#Professionals02 - Standards#X03565/4#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100599 #OBSERVER #C#Professionals

    Groups (European Parliament)

    N/A

    Communication activities

    The BioMed Alliance has addressed important issues for
    biomedical and health research in the EU such as: changes to the EU research budget, implementation of legislative dossiers and European Citizens’ Initiatives that could hamper research.

    Policy, strategy and activities are annually discussed during the Spring meeting and the General Assembly.

    Other activities

    None declared

  • Meetings

    Meetings

    4 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

    • Date 08 Apr 2021 Location online
      Subject Health Union
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Catherine Sustek (Cabinet member)
      • Margaritis Schinas (Vice-President)
      Other Lobbyists
    • Date 05 Feb 2020 Location Brussels
      Subject Health research, ERA, Horizon Europe priorities
      Cabinet Cabinet of Commissioner Mariya Gabriel
      Portfolio Digital Economy and Society
      Attending
      • Mariya Gabriel (Commissioner)
    • Date 05 Feb 2020 Location Brussels
      Subject Health research, ERA, Horizon Europe priorities
      Cabinet Cabinet of Commissioner Mariya Gabriel
      Portfolio Innovation and Youth
      Attending
      • Mariya Gabriel (Commissioner)
    • Date 08 Mar 2018 Location Brussels
      Subject European Reference Networks; Health research
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
Download this datacard